HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome

PURPOSE: Apocrine carcinoma of the breast (APO) expresses HER2 in 30–50% of cases. This study explored the clinicopathological features and outcome of HER2+/APO and matched HER2+/NST cohort. METHODS: We used the SEER database to explore the cohorts. Univariate and multivariate analyses were used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Skenderi, Faruk, Alahmad, Mohamad Alhoda Mohamad, Tahirovic, Emin, Alahmad, Yaman M., Gatalica, Zoran, Vranic, Semir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090698/
https://www.ncbi.nlm.nih.gov/pubmed/35355162
http://dx.doi.org/10.1007/s10549-022-06578-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090698/
https://www.ncbi.nlm.nih.gov/pubmed/35355162
http://dx.doi.org/10.1007/s10549-022-06578-4

Ejemplares similares